Tuberculosis is still one of the deadliest infectious diseases in the world, with 1.3 million people dying from TB in 2022 alone per the World Health Organization (WHO). Despite the global community having set itself the goal of ending TB by 2035, this is not realistic. This is because, although there are existing tests and drugs that can successfully diagnose and treat TB, these lifesaving medical products are often not accessible to people with TB who need them.
For many years, the German government has supported measures to control TB worldwide, but why is the German government satisfied with a mediocre impact when it could save many more lives with this investment?
